Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company based in California. Its filings show it engages with Congress on issues related to the U.S. Food and Drug Administration (FDA), mainly around medical and clinical research matters. The company used a lobbyist firm, Continental Strategy, LLC, but reported no spending in the filing.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
LUKE NICKLESS
The latest disclosures for this client.
CONTINENTAL STRATEGY, LLC
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
CONTINENTAL STRATEGY, LLC
TIMOTHY COSTA
CONTINENTAL STRATEGY, LLC